Applied Dna Sciences Inc [NASDAQ: APDN] loss -40.56% on the last trading session, reaching $0.19 price per share at the time.
If compared to the average trading volume of 10.76M shares, APDN reached a trading volume of 23098249 in the most recent trading day, which is why market watchdogs consider the stock to be active.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Here is what top equities market gurus are saying about Applied Dna Sciences Inc [APDN]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for APDN shares is $1.50 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on APDN stock is a recommendation set at 3.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
ROTH Capital have made an estimate for Applied Dna Sciences Inc shares, keeping their opinion on the stock as Buy, with their previous recommendation back on February 12, 2021. While these analysts kept the previous recommendation, H.C. Wainwright dropped their target price from $18 to $14. The new note on the price target was released on January 14, 2021, representing the official price target for Applied Dna Sciences Inc stock. Previously, the target price had yet another drop from $20 to $12, while H.C. Wainwright kept a Buy rating on APDN stock. On July 20, 2020, analysts increased their price target for APDN shares from 18 to 22.
The Average True Range (ATR) for Applied Dna Sciences Inc is set at 0.10, with the Price to Sales ratio for APDN stock in the period of the last 12 months amounting to 0.57. The Price to Book ratio for the last quarter was 0.16, with the Price to Cash per share for the same quarter was set at 1.01.
Trading performance analysis for APDN stock
Applied Dna Sciences Inc [APDN] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -45.85. With this latest performance, APDN shares dropped by -45.22% in over the last four-week period, additionally sinking by -95.32% over the last 6 months – not to mention a drop of -98.74% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for APDN stock in for the last two-week period is set at 27.64, with the RSI for the last a single of trading hit 20.56, and the three-weeks RSI is set at 33.33 for Applied Dna Sciences Inc [APDN]. The present Moving Average for the last 50 days of trading for this stock 0.9895, while it was recorded at 0.2865 for the last single week of trading, and 4.2801 for the last 200 days.
Applied Dna Sciences Inc [APDN]: A deeper dive into fundamental analysis
Applied Dna Sciences Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 3.76 and a Current Ratio set at 3.91.
Applied Dna Sciences Inc [APDN]: An earnings per share (EPS) analysis
With the latest financial reports released by the company, Applied Dna Sciences Inc posted -5.2/share EPS, while the average EPS was predicted by analysts to be reported at -5.4/share. When compared, the two values demonstrate that the company surpassed the estimates by a Surprise Factor of 0.2. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for APDN.
An analysis of Institutional ownership at Applied Dna Sciences Inc [APDN]
There are presently around $11.90%, or 12.28%% of APDN stock, in the hands of institutional investors.
